The year is half over. Here is where the biotechnology industry is located

Adam Feuerstein is a main writer and biotechnology columnist, reporting on the crossroads of drug development, business, Wall Street and biotechnology. He is also co-host of the weekly biotech podcast The Readout Loud and author of the Biotech dashboard of the Adam newsletter. You can reach Adam on the signal to stataf.54.

This is the online version of Adam’s Biotech Scorecard, a newsletter only subscribed. Stat + subscribers can register here to have it delivered in their reception box.

I don’t know if this newsletter is reading beach, but I hope you enjoy the long weekend of July, wherever you take it. And if you want to look at what happens this quarter, my third trimester dashboard came out.

It could be better, could be worse

The atmosphere is better than the figures suggest. The panic of the Doom loop in March and April is behind us, even if the XBI exchange blurred since the May recovery. Have you heard of Fomo? Well, biotechnology is simply MO – missing the wider market rally. Does anyone remember the last time Biotech participated?